James T. Parsons Insider Trading $TRIL Trillium Therapeutics Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James T. Parsons.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James T. Parsons. James T. Parsons is Director in DiaMedica Therapeutics Inc. ($DMAC) and Chief Financial Officer in Trillium Therapeutics Inc. ($TRIL).

James T. Parsons in Trillium Therapeutics Inc.

Trading Symbol: TRIL
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James T. Parsons: Chief Financial Officer
Holdings: 8,505 shares
Latest Transaction: Jan 12 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of James T. Parsons in Trillium Therapeutics Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, DMAC, TRIL

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 12 2021TRILTrillium Therapeut ...Parsons James T.Chief Financial Off ...Option ExerciseM7.248,50561,6165,761
Jan 12 2021TRILTrillium Therapeut ...Parsons James T.Chief Financial Off ...SellS15.798,505134,27108.5 K to 0 (-100.00 %)
Jan 12 2021TRILTrillium Therapeut ...Parsons James T.Chief Financial Off ...BuyM7.248,50561,6168,5050 to 8.5 K

Page:   1